Patients with acute respiratory distress syndrome (ARDS) often require mechanical ventilation (MV), which further induces lung injury (ventilator-induced lung injury, VILI). VILI is associated with substantial morbidity and mortality both in mechanically ventilated patients with, and without ARDS. Pneumonia (PA) is a primary risk factor for development of ARDS in humans. In rodents, VILI and PA have been extensively used as experimental acute lung injury (ALI) models to study the pathogenesis of ARDS. The scientific premise of this grant is that receptor-interacting protein-3 kinase (RIPK3) is crucial for the propagation of necroptotic cell death and inflammation in the pathogenesis of experimental ALI (VILI and PA models) and in human disease such as ARDS. We have obtained intriguing preliminary data demonstarting that RIPK3 expression is regulated in ALI, and that RIPK3-deficient mice are protected against ALI (in both VILI and PA models), strongly suggesting that the RIPK3-dependent necroptosis pathway is crucial for mediating the pathogenesis of experimental ALI. We further show that metabolic dysfunction such as dysregulated fatty acid (FA) metabolism results in activation of RIPK3-dependent signaling and necroptosis and that disruption of FA metabolism promotes macrophage inflammasome activation and pro-inflammatory cytokines production, which contributes to the development of ALI. We also show also that FA synthesis and mitochondrial NADPH:oxidase-4 (NOX4) are required for NLRP3-mediated inflammasome activation in macrophages. In human studies, we demonstrate that not only are inflammasome regulated cytokines associated with mortality of the critically ill patients but both necroptosis proteins RIPK3 and FA are regulated in patients with critical illness. Based on these studies, we propose the following hypothesis: Sterile injurious mechanical ventilation or pneumonia infection causes metabolic and FA dysfunction resulting in activation of RIPK3-dependent signaling and necroptosis. Disruption of FA metabolism by mechanical injury or infection promotes macrophage NOX4-dependent inflammasome activation and pro-inflammatory cytokines production, which contribute to the development of ALI. We also hypothesize that necroptosis-related proteins and FA are associated with morbidity and mortality in patients with critical illness, including ARDS. We will test our hypothesis by addressing the following Specific Aims:
Specific Aim 1 : To determine the regulation and function of RIPK3-dependent necroptosis in ALI.
Specific Aim 2 : To determine the mechanisms by which necroptosis mediates NOX4-dependent NLRP3 inflammasome activation in ALI.
Specific Aim 3 : To determine the clinical relevance of necroptosis and FA metabolism in the critically ill patients, including ARDS.

Public Health Relevance

Ventilator-induced lung and pneumonia have been extensively used as experimental acute lung injury models to study the pathogenesis of human acute respiratory distress syndrome (ARDS). This project will address the mechanisms by which mechanical ventilation and pneumonia injure the lung through disruption of fatty acid metabolism and regulation of cell death and inflammation pathways. This project will also attempt to determine the clinical relevance of necroptosis and fatty acid metabolism in critically ill patients, including those with ARDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055330-21
Application #
9675315
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Zhou, Guofei
Project Start
1996-07-01
Project End
2022-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
21
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Ma, Kevin C; Schenck, Edward J; Pabon, Maria A et al. (2018) The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness. Am J Respir Crit Care Med 197:300-309
Schenck, Edward J; Oromendia, Clara; Torres, Lisa K et al. (2018) Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials. Chest :
Schenck, Edward J; Ma, Kevin C; Murthy, Santosh B et al. (2018) Danger Signals in the ICU. Crit Care Med 46:791-798
Ryter, Stefan W; Ma, Kevin C; Choi, Augustine M K (2018) Carbon monoxide in lung cell physiology and disease. Am J Physiol Cell Physiol 314:C211-C227
Harrington, John S; Schenck, Edward J; Oromendia, Clara et al. (2018) Acute respiratory distress syndrome without identifiable risk factors: A secondary analysis of the ARDS network trials. J Crit Care 47:49-54
Siempos, Ilias I; Ma, Kevin C; Imamura, Mitsuru et al. (2018) RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury. JCI Insight 3:
Finkelsztein, Eli J; Jones, Daniel S; Ma, Kevin C et al. (2017) Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit. Crit Care 21:73
Lee, Seonmin; Nakahira, Kiichi; Dalli, Jesmond et al. (2017) NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis. Am J Respir Crit Care Med 196:713-726
Zhang, Ruoyu; Nakahira, Kiichi; Guo, Xiaoxian et al. (2016) Very Short Mitochondrial DNA Fragments and Heteroplasmy in Human Plasma. Sci Rep 6:36097
Ryter, Stefan W; Choi, Augustine M K (2016) Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res 167:7-34

Showing the most recent 10 out of 113 publications